4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-417068
See Remarks sold 58,333 shares at an average $12.92 ($753,937)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David See Remarks | 2026-10-05 | Sale 10b5-1 | −58,061 | $12.92 | $750,235 | 709,425 | D: show line 1 in the form |
| Kirn David See Remarks | 2026-10-05 | Sale 10b5-1 | −272 | $13.61 | $3,702 | 709,153 | D: show line 2 in the form |
| Open-market sales · 58,333 sh · avg $12.92 · $753,937 | |||||||
Loading xslF345X06/ownership.xml…